Joshua R. Disbrow
2021 - AYTU BIOPHARMA
In 2021, Joshua R. Disbrow earned a total compensation of $6.2M as Chief Executive Officer since December at AYTU BIOPHARMA, a 291% increase compared to previous year.
Compensation breakdown
| Bonus | $462,203 |
|---|---|
| Salary | $545,000 |
| Stock Awards | $5,192,000 |
| Total | $6,199,203 |
Disbrow received $5.2M in stock awards, accounting for 84% of the total pay in 2021.
Disbrow also received $462.2K in bonus and $545K in salary.
Rankings
In 2021, Joshua R. Disbrow's compensation ranked 2,044th out of 12,415 executives tracked by ExecPay. In other words, Disbrow earned more than 83.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,044 out of 12,415 | 84th |
Division Manufacturing | 784 out of 5,508 | 86th |
Major group Chemicals And Allied Products | 305 out of 2,378 | 87th |
Industry group Drugs | 264 out of 2,099 | 87th |
Industry Pharmaceutical Preparations | 172 out of 1,549 | 89th |
Source: SEC filing on April 7, 2022.
Disbrow's colleagues
We found two more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2021.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019